Osteosarcoma: Molecular Pathogenesis and iPSC Modeling
Open accessAbstract
Rare hereditary disorders provide unequivocal evidence of the importance of genes in human disease pathogenesis. Familial syndromes that predispose to osteosarcomagenesis are invaluable in understanding the underlying genetics of this malignancy. Recently, patient-derived induced pluripotent stem cells (iPSCs) have been successfully utilized to model Li-Fraumeni syndrome (LFS)-associated bone malignancy, demonstrating that iPSCs can serve as an in vitro disease model to elucidate osteosarcoma etiology. We provide here an overview of osteosarcoma predisposition syndromes and review recently established iPSC disease models for these familial syndromes. Merging molecular information gathered from these models with the current knowledge of osteosarcoma biology will help us to gain a deeper understanding of the pathological mechanisms underlying osteosarcomagenesis and will potentially aid in the development of future patient therapies.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Introduction of TP53 mutations into partially differentiated osteogenic stem cells generated osteosarcoma-like cells in vitro.
“Introduction of TP53 mutations into partially differentiated osteogenic stem cells generated osteosarcoma-like cells in vitro 31 .”
From Osteosarcoma (2022) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221 · see citing works
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765 · see citing works
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163 · see citing works
Liao, J., Wei, Q., Zou, Y., Fan, J., Song, D., Cui, J., Zhang, W., Zhu, Y., Ma, C., Hu, X. Y., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471945 · Cited by 2,742 · see citing works
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414 · see citing works
The Epidemiology of Osteosarcoma
Ottaviani, G., & Jaffe, N. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0284-9_1 · Cited by 1,793 · see citing works
Effects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755 · see citing works
Soft-Tissue Sarcomas, Breast Cancer, and Other Neoplasms
Li, F. P., & FRAUMENI, J. F. (1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-71-4-747 · Cited by 1,514 · see citing works
The Bloom's syndrome gene product is homologous to RecQ helicases
Ellis, N. A., Groden, J. L., Ye, T.-Z., Straughen, J. E., Lennon, D. J., Ciocci, S., Proytcheva, M. A., & GERMAN, J. L. (1995) · Cell · doi:10.1016/0092-8674(95)90105-1 · Cited by 1,385 · see citing works
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., & Jacks, T. (2004) · Cell · doi:10.1016/j.cell.2004.11.004 · Cited by 1,308 · see citing works
Translational biology of osteosarcoma
Kansara, M., Teng, M. W., Smyth, M. J., & Thomas, D. M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3838 · Cited by 1,294 · see citing works
A cancer family syndrome in twenty-four kindreds.
Li, F. P., Fraumeni, J. F., Mulvihill, J. J., Blattner, W. A., Dreyfus, M., Tucker, M., & Miller, R. (1988) · PubMed · Cited by 1,293 · see citing works
Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
Lee, E. Y.-H. P., Chang, C.-Y., Hu, N., Wang, Y.-C. J., Lai, C., Herrup, K., Lee, W., & Bradley, A. (1992) · Nature · doi:10.1038/359288a0 · Cited by 1,264 · see citing works
Mutant p53: one name, many proteinsPreprint
Freed-Pastor, W. A., & Prives, C. L. (2012) · Genes & Development · doi:10.1101/gad.190678.112 · Cited by 1,246 · see citing works
The Bloom's syndrome helicase suppresses crossing over during homologous recombination
Wu, L., & Hickson, I. D. (2003) · Nature · doi:10.1038/nature02253 · Cited by 1,087 · see citing works
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
Lang, G. A., Iwakuma, T., Suh, Y.-A., Liu, G., Rao, V. A., Parant, J. M., Valentin-Vega, Y. A., Terzian, T., Caldwell, L. C., Strong, L. C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.006 · Cited by 1,069 · see citing works
Requirement for a functional Rb-1 gene in murine development
Clarke, A. R., Maandag, E. R., van ROON, M. A., van der Lugt, N. M. T., van der Valk, M., Hooper, M., Berns, A. J. M., & Rielef, H. T. (1992) · Nature · doi:10.1038/359328a0 · Cited by 1,006 · see citing works
Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway
Freed-Pastor, W. A., Mizuno, H., Zhao, X., Langerød, A., Moon, S.-H., Rodriguez-Barrueco, R., Barsotti, A., Chicas, A., Li, W., Polotskaia, A., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.017 · Cited by 865 · see citing works
Ribosomopathies: human disorders of ribosome dysfunction
Narla, A., & Ebert, B. L. (2010) · Blood · doi:10.1182/blood-2009-10-178129 · Cited by 806 · see citing works
p62/ SQSTM 1 functions as a signaling hub and an autophagy adaptor
Katsuragi, Y., Ichimura, Y., & Komatsu, M. (2015) · FEBS Journal · doi:10.1111/febs.13540 · Cited by 795 · see citing works
Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
Chen, X., Bahrami, A., Pappo, A., Easton, J., Dalton, J., Hedlund, E., Ellison, D., Shurtleff, S., Wu, G., Wei, L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.003 · Cited by 752 · see citing works
Tumor Induction and Tissue Atrophy in Mice Lacking E2F-1
Yamasaki, L., Jacks, T., Bronson, R. T., Goillot, E., Harlow, E., & Dyson, N. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81254-4 · Cited by 699 · see citing works
Cancer Incidence After Retinoblastoma
Wong, F. L. (1997) · JAMA · doi:10.1001/jama.278.15.1262 · Cited by 689 · see citing works
Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families With p53 Germline Mutations
Hagman, K. D. F., Noltner, K., Buzin, C. H., Gu, D., Wen, C. Y., Nguyen, V. Q., Han, J., Lowstuter, K. J., Longmate, J., Sommer, S. S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.6959 · Cited by 607 · see citing works
p62 Is a Key Regulator of Nutrient Sensing in the mTORC1 Pathway
Durán, Á., Amanchy, R., Linares, J. F., Joshi, J. P., Abu‐Baker, S., Porollo, A., Hansen, M., Moscat, J., & Díaz-Meco, M. T. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.06.038 · Cited by 502 · see citing works
The Bloom's syndrome gene product promotes branch migration of Holliday junctions
Karow, J., Constantinou, A., Li, J., West, S. C., & Hickson, I. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100448097 · Cited by 502 · see citing works
Induced Pluripotent Stem Cells Meet Genome Editing
Hockemeyer, D., & Jaenisch, R. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.04.013 · Cited by 499 · see citing works
Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth
Zhu, J., Sammons, M. A., Donahue, G., Dou, Z., Vedadi, M., Getlik, M., Barsyte-Lovejoy, D., Al-awar, R., Katona, B. W., Shilatifard, A., et al. (2015) · Nature · doi:10.1038/nature15251 · Cited by 493 · see citing works
Induced pluripotent stem cells — opportunities for disease modelling and drug discovery
Grs̆ković, M., Javaherian, A., Strulovici, B., & Daley, G. Q. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3577 · Cited by 474 · see citing works
Vlachos, A., Ball, S. E., Dahl, N., Alter, B. P., Sheth, S., Ramenghi, U., Meerpohl, J. J., Karlsson, S., Liu, J. M., Leblanc, T. M., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07269.x · Cited by 474 · see citing works
Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling
Weissmueller, S., Manchado, E., Saborowski, M., Morris, J. P., Wagenblast, E., Davis, C. A., Moon, S.-H., Pfister, N. T., Tschaharganeh, D. F., Kitzing, T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.01.066 · Cited by 466 · cited 1× · see citing works
“Mutant p53 also upregulates PDGFRb by inhibiting the p73/NF-Y complex, leading to further invasion and metastasis in a pancreatic cancer mouse model [37].”
BackgroundThe premature ageing syndrome protein, WRN, is a 3′→5′ exonuclease
Huang, S., Li, B., Gray, M. D., Oshima, J., Mian, S. I., & Campisi, J. (1998) · Nature Genetics · doi:10.1038/2410 · Cited by 453 · see citing works
p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM
Song, H., Hollstein, M., & Xu, Y. (2007) · Nature Cell Biology · doi:10.1038/ncb1571 · Cited by 442 · see citing works
Excess of rare cancers in Werner syndrome (adult progeria).
Goto, M., Miller, R. W., Ishikawa, Y., & Sugano, H. (1996) · PubMed · Cited by 434 · see citing works
Chan, K., North, P. S., & Hickson, I. D. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601777 · Cited by 420 · see citing works
Gazda, H. T., Sheen, M. R., Vlachos, A., Choesmel, V., O’Donohue, M.-F., Schneider, H. E., Darras, N., Hasman, C., Sieff, C. A., Newburger, P. E., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.11.004 · Cited by 417 · see citing works
p62 in Cancer: Signaling Adaptor Beyond Autophagy
Moscat, J., Karin, M., & Díaz-Meco, M. T. (2016) · Cell · doi:10.1016/j.cell.2016.09.030 · Cited by 392 · see citing works
Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation
Funato, K., Major, T., Lewis, P. W., Allis, C. D., & Tabar, V. (2014) · Science · doi:10.1126/science.1253799 · Cited by 390 · see citing works
The Pediatric Cancer Genome Project
Downing, J. R., Wilson, R. K., Zhang, J., Mardis, E. R., Pui, C., Ding, L., Ley, T. J., & Evans, W. E. (2012) · Nature Genetics · doi:10.1038/ng.2287 · Cited by 375 · see citing works
Osteosarcoma Development and Stem Cell Differentiation
Tang, N., Song, W., Luo, J., Haydon, R. C., & He, T. (2008) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-008-0335-z · Cited by 355 · see citing works
2009 Version of the Chompret Criteria for Li Fraumeni Syndrome
Tinat, J., Bougeard, G., Baert‐Desurmont, S., Vasseur, S., Martin, C., Bouvignies, E., Caron, O., Paillerets, B. B., Berthet, P., Dugast, C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.7967 · Cited by 348 · see citing works
Roodman, G. D., & Windle, J. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24281 · Cited by 340 · see citing works
Wang, L. L., Gannavarapu, A., Kozinetz, C. A., Levy, M. L., Lewis, R. A., Chintagumpala, M. M., Ruiz-Maldanado, R., Contreras-Ruiz, J., Cunniff, C., Erickson, R. P., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.9.669 · Cited by 338 · see citing works
Self-citationRole of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth
Graña, X., Garriga, J., & Mayol, X. (1998) · Oncogene · doi:10.1038/sj.onc.1202575 · Cited by 328 · see citing works
Bloom's syndrome. XX. The first 100 cancers
GERMAN, J. L. (1997) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(96)00336-6 · Cited by 318 · see citing works
Clinical manifestations in a cohort of 41 Rothmund-Thomson syndrome patients
Wang, L. L., Levy, M. L., Lewis, R. A., Chintagumpala, M., Lev, D., Rogers, M., & Plon, S. E. (2001) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20010722)102:1 · Cited by 316 · see citing works
Self-citationRb regulates fate choice and lineage commitment in vivo
Calo, E., Quintero-Estades, J. A., Danielian, P. S., Nedelcu, S., Berman, S. D., & Lees, J. A. (2010) · Nature · doi:10.1038/nature09264 · Cited by 313 · see citing works
Vlachos, A., Rosenberg, P. S., Atsidaftos, E., Alter, B. P., & Lipton, J. M. (2012) · Blood · doi:10.1182/blood-2011-08-375972 · Cited by 309 · see citing works
Initiation of DNA replication requires the RECQL4 protein mutated in Rothmund-Thomson syndrome.
Sangrithi, M. N., Bernal, J. A., Madine, M. A., Philpott, A., Lee, J.-K., Dunphy, W. G., & Venkitaraman, A. (2005) · Cell · doi:10.1016/j.cell.2005.05.015 · Cited by 305 · see citing works
Altered translation of GATA1 in Diamond-Blackfan anemia
Ludwig, L. S., Gazda, H. T., Eng, J. C., Eichhorn, S. W., Thiru, P., Ghazvinian, R., George, T. I., Gotlib, J. R., Beggs, A. H., Sieff, C. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3557 · Cited by 302 · see citing works
Using Epidemiology and Genomics to Understand Osteosarcoma Etiology
Savage, S. A., & Mirabello, L. J. (2011) · Sarcoma · doi:10.1155/2011/548151 · Cited by 301 · see citing works
Danilova, N., Sakamoto, K. M., & Lin, S. L. (2008) · Blood · doi:10.1182/blood-2008-01-132290 · Cited by 291 · see citing works
Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis
Hanel, W. G., Marchenko, N. D., Xu, S., Yu, S., Weng, W., & Moll, U. M. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.17 · Cited by 278 · see citing works
Bloom's Syndrome: Clinical Spectrum, Molecular Pathogenesis, and Cancer Predisposition
Cunniff, C. M., Bassetti, J. A., & Ellis, N. A. (2016) · Molecular Syndromology · doi:10.1159/000452082 · Cited by 267 · see citing works
Osteoblast differentiation and skeletal development are regulated by Mdm2–p53 signaling
Lengner, C. J., Steinman, H. A., Gagnon, J. A., Smith, T. W., Henderson, J. E., Kream, B. E., Stein, G. S., Lian, J. B., & Jones, S. N. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200508130 · Cited by 266 · see citing works
The Retinoblastoma-Histone Deacetylase 3 Complex Inhibits PPARγ and Adipocyte Differentiation
Lluis Fajas, A., Egler, V., Reiter, R. J., Hansen, J. B., Kristiansen, K., Debril, M.-B., Miard, S., & Auwerx, J. H. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00360-x · Cited by 258 · see citing works
K63 Polyubiquitination and Activation of mTOR by the p62-TRAF6 Complex in Nutrient-Activated Cells
Linares, J. F., Durán, Á., Yajima, T., Pasparakis, M., Moscat, J., & Díaz-Meco, M. T. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.06.020 · Cited by 256 · see citing works
Syndrome-causing mutations of theBLMgene in persons in the Bloom's Syndrome Registry
GERMAN, J. L., Sanz, M. M., Ciocci, S., Ye, T. Z., & Ellis, N. A. (2007) · Human Mutation · doi:10.1002/humu.20501 · Cited by 252 · see citing works
Wang, X., Kua, H.-Y., Hu, Y., Guo, K., Zeng, Q., Wu, Q., Ng, H., Karsenty, G., Crombrugghe, B. D., Yeh, J. K., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200507106 · Cited by 250 · see citing works
BLOOM, D. (1954) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1954.02050100756008 · Cited by 240 · see citing works
Moriarity, B. S., Otto, G. M., Rahrmann, E. P., Rathe, S. K., Wolf, N. K., Weg, M. T., Manlove, L. A., LaRue, R. S., Temiz, N. A., Molyneux, S. D., et al. (2015) · Nature Genetics · doi:10.1038/ng.3293 · Cited by 238 · see citing works
Spectrum and Risk of Neoplasia in Werner Syndrome: A Systematic Review
Lauper, J. M., Krause, A. J., Vaughan, T. L., & Monnat, R. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059709 · Cited by 234 · see citing works
The mutation spectrum in RECQL4 diseases
Siitonen, H. A., Sotkasiira, J., Biervliet, M., Benmansour, A., Capri, Y., Cormier‐Daire, V., Crandall, B. F., Hannula‐Jouppi, K., Hennekam, R. C. M., Herzog, D., et al. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.154 · Cited by 234 · see citing works
Self-citationPatterns of ribosomal protein expression specify normal and malignant human cells
Guimaraes, J. C., & Zavolan, M. (2016) · Genome biology · doi:10.1186/s13059-016-1104-z · Cited by 233 · see citing works
Ottaviani, G., & Jaffe, N. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0284-9_2 · Cited by 232 · see citing works
Modeling Familial Cancer with Induced Pluripotent Stem Cells
Lee, D., Su, J., Kim, H. S., Chang, B., Papatsenko, D., Zhao, R., Yuan, Y., Gingold, J. A., Xia, W., Darr, H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.02.045 · Cited by 223 · see citing works
Self-citationPreferential mutation of paternally derived RB gene as the initial event in sporadic osteosarcoma
Toguchida, J., Ishizaki, K., Sasaki, M. S., Nakamura, Y., Ikenaga, M., Kato, M. V., Sugimot, M., Kotoura, Y., & Yamamuro, T. (1989) · Nature · doi:10.1038/338156a0 · Cited by 215 · see citing works
Macias, E., Jin, A., Deisenroth, C., Bhat, K., Mao, H., Lindström, M. S., & Zhang, Y. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.007 · Cited by 214 · see citing works
A common gain of function of p53 cancer mutants in inducing genetic instability
Liu, D., Song, H., & Xu, Y. (2009) · Oncogene · doi:10.1038/onc.2009.376 · Cited by 214 · see citing works
Osteosarcoma in Paget's Disease of Bone
Hansen, M. F., Seton, M., & Merchant, A. S. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.06s211 · Cited by 209 · see citing works
Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma
Thomas, D. M., Johnson, S. A. S., Sims, N. A., Trivett, M. K., Slavin, J., Rubin, B. P., Waring, P., McArthur, G. A., Walkley, C. R., Holloway, A. J., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200409187 · Cited by 208 · see citing works
Survival with retinoblastoma in the USA: 1975-2004
Broaddus, E., Topham, A., & Singh, A. D. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2008.143842 · Cited by 200 · see citing works
Molecular defect of RAPADILINO syndrome expands the phenotype spectrum of RECQL diseases
Siitonen, H. A. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg306 · Cited by 196 · see citing works
Matsuno, K., Kumano, M., Kubota, Y., Hashimoto, Y., & Takisawa, H. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02267-05 · Cited by 194 · see citing works
Im, J., Ki, S.-H., Farina, A., Jung, D.-S., Hurwitz, J., & Lee, J.-K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908039106 · Cited by 185 · see citing works
Physical and Functional Interaction between p53 and the Werner's Syndrome Protein
Blander, G., Kipnis, J., Martínez-Leal, J. F., Yu, C., Schellenberg, G. D., & Oren, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.29463 · Cited by 181 · see citing works
Haydon, R. C., Deyrup, A. T., Ishikawa, A., Heck, R. K., Jiang, W., Zhou, L., Feng, T., King, D., Cheng, H., Breyer, B. N., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10719 · Cited by 171 · see citing works
PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype
Duan, S., Yuan, G., Liu, X., Ren, R., Li, J., Zhang, W., Wu, J., Xu, X., Fu, L., Li, Y., et al. (2015) · Nature Communications · doi:10.1038/ncomms10068 · Cited by 169 · see citing works
RB1 dual role in proliferation and apoptosis: Cell fate control and implications for cancer therapy
Indovina, P., Pentimalli, F., Casini, N., Vocca, I., & Giordano, A. (2015) · Oncotarget · doi:10.18632/oncotarget.4286 · Cited by 162 · see citing works
p53 is balancing development, differentiation and de-differentiation to assure cancer prevention
Molchadsky, A., Rivlin, N., Brosh, R., Rotter, V., & Sarig, R. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq101 · Cited by 156 · see citing works
Mann, M. B. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi075 · Cited by 156 · see citing works
Functional Interaction of p53 and BLM DNA Helicase in Apoptosis
Wang, X. W., Tseng, A., Ellis, N. A., Spillare, E. A., Linke, S. P., Robles, A. I., Seker, H., Yang, Q., Hu, P., Beresten, S. F., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103298200 · Cited by 145 · see citing works
Pfister, N. T., Fomin, V., Regunath, K., Zhou, J. Y., Zhou, W., Silwal‐Pandit, L., Freed-Pastor, W. A., Laptenko, O., Neo, S. P., Bargonetti, J., et al. (2015) · Genes & Development · doi:10.1101/gad.263202.115 · Cited by 143 · see citing works
Modeling sarcomagenesis using multipotent mesenchymal stem cells
Rodrı́guez, R., Rubio, R., & Menéndez, P. R. (2011) · Cell Research · doi:10.1038/cr.2011.157 · Cited by 143 · see citing works
MCM10 mediates RECQ4 association with MCM2‐7 helicase complex during DNA replication
Xu, X., Rochette, P. J., Feyissa, E. A., Su, T., & Liu, Y. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.235 · Cited by 143 · see citing works
Cause-Specific Mortality in Long-Term Survivors of Retinoblastoma
Yu, C., Tucker, M. A., Abramson, D. H., Furukawa, K., Seddon, J. M., Stovall, M. A., Fraumeni, J. F., & Kleinerman, R. A. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp046 · Cited by 141 · see citing works
Regulation of Embryonic and Induced Pluripotency by Aurora Kinase-p53 Signaling
Lee, D., Su, J., Ang, Y.-S., Carvajal‐Vergara, X., Mulero‐Navarro, S., Pereira, C., Gingold, J. A., Wang, H.-L., Zhao, R., Sevilla, A., et al. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.05.020 · Cited by 137 · see citing works
Self-citationNotch Activation as a Driver of Osteogenic Sarcoma
Tao, J., Jiang, M., Jiang, L., Salvo, J. S., Zeng, H., Dawson, B., Bertin, T., Rao, P. H., Chen, R., Donehower, L. A., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.07.023 · Cited by 135 · see citing works
Lipton, J. M. M., Federman, N. C., Khabbaze, Y., Schwartz, C. L., Hilliard, L., Clark, J. I., & Vlachos, A. (2001) · The American journal of pediatric hematology/oncology · doi:10.1097/00043426-200101000-00009 · Cited by 132 · see citing works
Differential expression of genes coding for ribosomal proteins in different human tissues
Bortoluzzi, S., d’Alessi, F., Romualdi, C., & Danieli, G. A. (2001) · Bioinformatics · doi:10.1093/bioinformatics/17.12.1152 · Cited by 129 · see citing works
Petkovic, M., Dietschy, T., Freire, R., Jiao, R., & Štagljar, I. (2005) · Journal of Cell Science · doi:10.1242/jcs.02556 · Cited by 126 · see citing works
Ketteler, P., Arendt, M., Viehmann, A., Eisele, L., Guin, C. H. D. L., Schündeln, M. M., Biewald, E. M., Astrahantseff, K., Wieland, R., Bornfeld, N., et al. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.26193 · Cited by 126 · see citing works
Rea, S. L., Walsh, J. P., Layfield, R., Ratajczak, T., & Xu, J. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1034 · Cited by 123 · see citing works
The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types
Fancello, L., Kampen, K. R., Hofman, I. J., Verbeeck, J., & Keersmaecker, K. D. (2017) · Oncotarget · doi:10.18632/oncotarget.14895 · Cited by 123 · see citing works
The retinoblastoma tumor suppressor and stem cell biologyPreprint
Sage, J. (2012) · Genes & Development · doi:10.1101/gad.193730.112 · Cited by 119 · see citing works
The ribosomal protein S26 regulates p53 activity in response to DNA damage
Cui, D., Li, L., Lou, H., Sun, H., Ngai, S. H. O., Shao, G., & Tang, J. (2013) · Oncogene · doi:10.1038/onc.2013.170 · Cited by 119 · see citing works
Diverse diseases from a ubiquitous process: The ribosomopathy paradox
Armistead, J., & Triggs‐Raine, B. L. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.03.024 · Cited by 116 · see citing works
Vitamin C restores healthy aging in a mouse model for Werner syndrome
Massip, L., Garand, C., Paquet, É. R., Cogger, V. C., O'Reilly, J. N., Tworek, L., Hatherell, A., Taylor, C. G., Thorin, É., Zahradka, P. C., et al. (2009) · The FASEB Journal · doi:10.1096/fj.09-137133 · Cited by 114 · see citing works
Growth retardation and skin abnormalities of the Recql4-deficient mouse
Hoki, Y. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg254 · Cited by 114 · see citing works
Lamm, N., Ben‐David, U., Golan‐Lev, T., Štorchová, Z., Benvenisty, N., & Kerem, B. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.11.003 · Cited by 110 · see citing works
Kondoh, N., Schweinfest, C. W., Henderson, K. W., & Papas, T. S. (1992) · PubMed · Cited by 109 · see citing works
De, S., Kumari, J., Mudgal, R., Modi, P., Gupta, S., Futami, K., Goto, H., Lindor, N. M., Furuichi, Y., Mohanty, D., et al. (2012) · Journal of Cell Science · doi:10.1242/jcs.101501 · Cited by 107 · see citing works
Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitors
Doulatov, S. R., Vo, L. T., Macari, E. R., Wahlster, L., Kinney, M. A., Taylor, A. M., Barragan, J., Gupta, M., McGrath, K. E., Lee, H., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aah5645 · Cited by 105 · see citing works
Telomerase Protects Werner Syndrome Lineage-Specific Stem Cells from Premature Aging
Cheung, H.-H., Liu, X., Canterel-Thouennon, L., Li, L., Edmonson, C., & Rennert, O. M. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.02.006 · Cited by 102 · see citing works
WRN Mutation Update: Mutation Spectrum, Patient Registries, and Translational Prospects
Yokote, K., Chanprasert, S., Lee, L., Eirich, K., Takemoto, M., Watanabe, A., Koizumi, N., Lessel, D., Mori, T., Hisama, F. M., et al. (2016) · Human Mutation · doi:10.1002/humu.23128 · Cited by 100 · see citing works
Mesenchymal stem cell transformation and sarcoma genesis
Xiao, W., Mohseny, A. B., Hogendoorn, P. C. W., & Cleton-Jansen, A. (2013) · Clinical Sarcoma Research · doi:10.1186/2045-3329-3-10 · Cited by 99 · see citing works
RECQL4 Promotes DNA End Resection in Repair of DNA Double-Strand Breaks
Lu, H., Shamanna, R. A., Keijzers, G., Anand, R., Rasmussen, L. J., Ćejka, P., Croteau, D. L., & Bohr, V. A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.079 · Cited by 95 · see citing works
Garçon, L., Ge, J., Manjunath, S. H., Mills, J. A., Apicella, M., Parikh, S. P., Sullivan, L. M., Podsakoff, G. M., Gadue, P. J., French, D. L., et al. (2013) · Blood · doi:10.1182/blood-2013-01-478321 · Cited by 92 · see citing works
Rubio, R., Gutiérrez-Aranda, I., Sáez-Castillo, A. I., Labarga, A., Rosu‐Myles, M., González-García, S., Toribio, M. L., Menéndez, P. R., & Rodrı́guez, R. (2012) · Oncogene · doi:10.1038/onc.2012.507 · Cited by 91 · see citing works
Carrier Frequency of the Bloom SyndromeblmAshMutation in the Ashkenazi Jewish Population
Li, L., Eng, C. M., Desnick, R. J., GERMAN, J. L., & Ellis, N. A. (1998) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1998.2733 · Cited by 88 · see citing works
Lorenz, S., Barøy, T., Sun, J., Nome, T., Vodák, D., Bryne, J. C., Håkelien, A.-M., Fernandez‐Cuesta, L., Möhlendick, B., Rieder, H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6567 · Cited by 87 · see citing works
Direct and indirect roles of RECQL4 in modulating base excision repair capacity
Schurman, S. H., Hedayati, M. A., Wang, Z., Singh, D. K., Speina, E., Zhang, Y., Becker, K. G., Macris, M. A., Sung, P., Wilson, D. M., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp291 · Cited by 85 · see citing works
Epidemiology and Rb1 gene of retinoblastoma.
Yun, J., Li, Y., Xu, C.-T., & Pan, B.-R. (2011) · PubMed Central · doi:10.3980/j.issn.2222-3959.2011.01.24 · Cited by 84 · see citing works
Mulero‐Navarro, S., Sevilla, A., Román, Á., Lee, D., D’Souza, S. L., Pardo, S., Riess, I., Su, J., Cohen, N., Schaniel, C., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.019 · Cited by 83 · see citing works
Self-citationIchikawa, K., Noda, T., & Furuichi, Y. (2002) · Folia Pharmacologica Japonica · doi:10.1254/fpj.119.219 · Cited by 82 · see citing works
Pinto, C., Kasaciunaite, K., Seidel, R., & Ćejka, P. (2016) · eLife · doi:10.7554/elife.18574 · Cited by 82 · see citing works
The Rb–E2F Transcriptional Regulatory Pathway in Tumor Angiogenesis and Metastasis
Schaal, C. M., Pillai, S., & Chellappan, S. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-800249-0.00004-4 · Cited by 78 · see citing works
Vitamin C alleviates aging defects in a stem cell model for Werner syndrome
Li, Y., Zhang, W., Chang, L., Han, Y., Sun, L., Gong, X., Tang, H., Liu, Z., Deng, H., Ye, Y., et al. (2016) · Protein & Cell · doi:10.1007/s13238-016-0278-1 · Cited by 78 · see citing works
The Ribosomal Protein S19 Suppresses Antitumor Immune Responses via the Complement C5a Receptor 1
Markiewski, M. M., Vadrevu, S. K., Sharma, S., Chintala, N. K., Ghouse, S. M., Cho, J., Fairlie, D. P., Paterson, Y. Y. W., Astrinidis, A., & Karbowniczek, M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1602057 · Cited by 78 · see citing works
Absence of the p53 tumor suppressor gene promotes osteogenesis in mesenchymal stem cells
Tataria, M., Quarto, N., Longaker, M. T., & Sylvester, K. G. (2006) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2005.12.001 · Cited by 76 · see citing works
The Evolution of the Ribosomal Protein–MDM2–p53 PathwayPreprint
Deisenroth, C., Franklin, D. A., & Zhang, Y. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026138 · Cited by 74 · see citing works
The p62 P392L Mutation Linked to Paget’s Disease Induces Activation of Human Osteoclasts
Chamoux, E., Couture, J., Bisson, M., Morissette, J., Brown, J. P., & Roux, S. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0066 · Cited by 73 · see citing works
Fan, W., & Luo, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801928200 · Cited by 72 · see citing works
Bloom’s syndrome: Why not premature aging?
de Renty, C., & Ellis, N. A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.05.010 · Cited by 72 · see citing works
The Bloom's syndrome helicase stimulates the activity of human topoisomerase IIIalpha
Wu, L. J. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf611 · Cited by 66 · see citing works
Impaired bone development and increased mesenchymal progenitor cells in calvaria of RB1 −/− mice
Gutierrez, G. M., Kong, E., Sabbagh, Y., Brown, N. E., Lee, J.-S., Demay, M. B., Thomas, D. M., & Hinds, P. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805925105 · Cited by 65 · see citing works
Mehollin-Ray, A. R., Kozinetz, C. A., Schlesinger, A. E., Guillerman, R. P., & Wang, L. L. (2008) · American Journal of Roentgenology · doi:10.2214/ajr.07.3619 · Cited by 65 · see citing works
Self-citationOsteosarcoma: Pathology and classification
Unni, K. K., & Dahlin, D. C. (1989) · Seminars in Roentgenology · doi:10.1016/0037-198x(89)90010-2 · Cited by 64 · see citing works
Wijnhoven, S., Zwart, E., Speksnijder, E. N., Beems, R. B., Olive, K. P., Tuveson, D. A., Jonkers, J., Schaap, M. M., van den Berg, J., Jacks, T., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1650 · Cited by 64 · see citing works
CDK1 phosphorylates WRN at collapsed replication forks
Palermo, V., Rinalducci, S., Sanchez, M., Grillini, F., Sommers, J. A., Brosh, R. M., Zolla, L., Franchitto, A., & Pichierri, P. (2016) · Nature Communications · doi:10.1038/ncomms12880 · Cited by 64 · see citing works
Shimamoto, A., Kagawa, H., Kazumasa, Z., Sera, Y., Kazuki, Y., Osaki, M., Oshimura, M., Ishigaki, Y., Hamasaki, K., Kodama, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112900 · Cited by 63 · see citing works
German, J., Bloom, D., Passarge, E., Fried, K., Goodman, R. M., KATZENELLENBOGEN, I., Laron, Z., Legum, C., Levin, S., & Wahrman (1977) · Europe PMC (PubMed Central) · Cited by 62 · see citing works
RAPADILINO syndrome with radial and patellar aplasia/hypoplasia as main manifestations
Kääriäinen, H., Ryöppy, S., & Norio, R. (1989) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320330312 · Cited by 62 · see citing works
Gupta, S., De, S., Srivastava, V. K., Hussain, M., Kumari, J., Muniyappa, K., & Sengupta, S. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt315 · Cited by 62 · see citing works
Song, R., Tian, K., Wang, W., & Wang, L. (2015) · International Journal of Surgery · doi:10.1016/j.ijsu.2015.04.050 · Cited by 61 · see citing works
Self-citationThe impact of osteoblastic differentiation on osteosarcomagenesis in the mouse
Quist, T. S., Jin, H., Zhu, J.-F., Smith-Fry, K., Capecchi, M. R., & Jones, K. B. (2014) · Oncogene · doi:10.1038/onc.2014.354 · Cited by 58 · see citing works
RECQ helicase RECQL4 participates in non-homologous end joining and interacts with the Ku complex
Shamanna, R. A., Singh, D. K., Lu, H., Mirey, G., Keijzers, G., Salles, B., Croteau, D. L., & Bohr, V. A. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu137 · Cited by 58 · see citing works
Sit down, relax and unwind: structural insights into RecQ helicase mechanisms
Killoran, M. P., & Keck, J. L. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl538 · Cited by 57 · see citing works
Rey, M. A., Duffy, S. P., Brown, J. K., Kennedy, J. A., Dick, J. E., Dror, Y., & Tailor, C. S. (2008) · Haematologica · doi:10.3324/haematol.13359 · Cited by 56 · see citing works
Aging in Rothmund-Thomson syndrome and related RECQL4 genetic disorders
Lu, L., Jin, W., & Wang, L. L. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.06.002 · Cited by 52 · see citing works
Self-citationBadhai, J., Fröjmark, A.-S., Davey, E. J., Schuster, J., & Dahl, N. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.002 · Cited by 48 · see citing works
Wang, J., Wu, P., Chen, P. C.-H., Lee, C.-W., Chen, W., & Hung, S. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0226 · Cited by 48 · see citing works
Dyer, M. A. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.07.010 · Cited by 46 · see citing works
RECQ DNA Helicases and Osteosarcoma
Lu, L., Jin, W., Liu, H., & Wang, L. L. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-04843-7_7 · Cited by 45 · see citing works
Self-citationThe DNA Helicase Recql4 Is Required for Normal Osteoblast Expansion and Osteosarcoma Formation
Ng, A. J., Walia, M., Smeets, M. F. M. A., Mutsaers, A. J., Sims, N. A., Purton, L. E., Walsh, N. C., Martin, T. J., & Walkley, C. R. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005160 · Cited by 45 · see citing works
Diamond-Blackfan anemia: a ribosomal puzzle
Dianzani, I., & Loreni, F. (2008) · Haematologica · doi:10.3324/haematol.2008.000513 · Cited by 45 · see citing works
Absence of RECQL4 mutations in poikiloderma with neutropenia in Navajo and non‐Navajo patients
Wang, L. L., Gannavarapu, A., Clericuzio, C. L., Erickson, R. P., Irvine, A. D., & Plon, S. E. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.10057 · Cited by 39 · see citing works
Self-citationRECQL4 Regulates p53 Function In Vivo During Skeletogenesis
Lu, L., Harutyunyan, K. G., Jin, W., Wu, J., Yang, T., Chen, Y., Joeng, K. S., Bae, Y., Tao, J., Dawson, B., et al. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2436 · Cited by 38 · see citing works
Self-citationOsteocytes Serve as a Progenitor Cell of Osteosarcoma
Sottnik, J. L., Campbell, B., Mehra, R., Behbahani‐Nejad, O., Hall, C. L., & Keller, E. T. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24793 · Cited by 37 · see citing works
Kliszczak, M., Polášek-Sedláčková, H., Pitchai, G. P., Streicher, W. W., Krejčí, L., & Hickson, I. D. (2015) · Oncotarget · doi:10.18632/oncotarget.6342 · Cited by 37 · see citing works
A model for the phenotypic presentation of Werner's syndrome
Ostler, E. L., Wallis, C. V., Sheerin, A. N. P., & Faragher, R. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00194-2 · Cited by 35 · see citing works
Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome
Bagley, M. C., Davis, T., Murziani, P. G. S., Widdowson, C. S., & Kipling, D. (2010) · Pharmaceuticals · doi:10.3390/ph3061842 · Cited by 35 · see citing works
Modeling Cancer with Pluripotent Stem Cells
Gingold, J. A., Zhou, R., Lemischka, I. R., & Lee, D. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.07.007 · Cited by 35 · see citing works
Self-citationYang, J., Annala, M., Ji, P., Wang, G., Zheng, H., Codgell, D., Du, X., Fang, Z., Sun, B., Nykter, M., et al. (2014) · Journal of Hematology & Oncology · doi:10.1186/s13045-014-0076-2 · Cited by 33 · see citing works
The histogenesis of Ewing Sarcoma
Tu, J., Huo, Z., Gingold, J. A., Zhao, R., Shen, J., & Lee, D. (2017) · Cancer Reports and Reviews · doi:10.15761/crr.1000111 · Cited by 31 · see citing works
Self-citationDallaire, A., Proulx, S., Simard, M. J., & Lebel, M. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-940 · Cited by 28 · see citing works
Kehrli, K., Phelps, M., Lazarchuk, P., Chen, E. Y., Monnat, R., & Sidorova, J. M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.708594 · Cited by 27 · see citing works
BLM promotes the activation of Fanconi Anemia signaling pathway
Panneerselvam, J., Wang, H., Zhang, J., Che, R., Yu, H., & Fei, P. (2016) · Oncotarget · doi:10.18632/oncotarget.8707 · Cited by 26 · see citing works
Paget’s disease of bone: an osteoimmunological disorder?
Michou, L., Numan, M., Amiable, N., & Brown, J. P. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s88845 · Cited by 23 · see citing works
Evaluating the Role of p38 MAPK in the Accelerated Cell Senescence of Werner Syndrome Fibroblasts
Davis, T., Brook, A. C., Rokicki, M., Bagley, M. C., & Kipling, D. (2016) · Pharmaceuticals · doi:10.3390/ph9020023 · Cited by 23 · see citing works
Gebhardt, M. C. (1996) · Orthopedic Clinics of North America · doi:10.1016/s0030-5898(20)32089-7 · Cited by 21 · see citing works
Targeted inhibition of WRN helicase, replication stress and cancer
Orlovetskie, N., Serruya, R., Abboud-Jarrous, G., & Jarrous, N. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.11.004 · Cited by 18 · see citing works
Aumailley, L., Dubois, M. J., Garand, C., Marette, A., & Lebel, M. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.10.012 · Cited by 16 · see citing works
A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcomaPreprint
Chen, K. S.-M., Kwon, W. S., Kim, J., Heo, S. J., Kim, H. S., Kim, H. K., Kim, S. H., Lee, W. S., Chung, H. C., Rha, S. Y., et al. (2016) · Molecular Case Studies · doi:10.1101/mcs.a000992 · Cited by 16 · see citing works
On BLM helicase in recombination-mediated telomere maintenance
Rezazadeh, S. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-2379-0 · Cited by 13 · see citing works
Zeng, S., Liu, L., Ouyang, Q., Zhao, Y. D., Lin, G., Hu, L., & Li, W. (2016) · Stem Cell Research · doi:10.1016/j.scr.2016.08.015 · Cited by 9 · see citing works
Flagged first, then by citations
4 of the 170 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Beird, H. C., Bielack, S. S., Flanagan, A. M., Gill, J., Heymann, D., Janeway, K. A., Livingston, J. A., Roberts, R. D., Strauss, S. J., & Gorlick, R. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00409-y · Cited by 660 · see citing works
Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy
Chehelgerdi, M., Dehkordi, F. B., Chehelgerdi, M., Kabiri, H., Salehian-Dehkordi, H., Abdolvand, M. A., Salmanizadeh, S., Rashidi, M., Niazmand, A., Ahmadi, S., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01873-0 · Cited by 184 · see citing works
Zhao, W., Qin, P., Zhang, D., Cui, X., Gao, J., Yu, Z., Chai, Y., Wang, J., & Li, J. (2019) · Aging · doi:10.18632/aging.102406 · Cited by 115 · see citing works
Molecular mechanisms underpinning sarcomas and implications for current and future therapy
Damerell, V., Pepper, M. S., & Prince, S. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00647-8 · Cited by 114 · see citing works
KDM6B-mediated histone demethylation of LDHA promotes lung metastasis of osteosarcoma
Jiang, Y., Li, F., Gao, B., Ma, M., Chen, M., Wu, Y., Zhang, W., Sun, Y., Liu, S., & Shen, H. (2021) · Theranostics · doi:10.7150/thno.53347 · Cited by 91 · see citing works
Имянитов, Е. Н., Kuligina, E. S., Соколенко, А. П., Suspitsin, E. N., Yanus, G. A., Iyevleva, A. G., Ivantsov, A. O., & Алексахина, С. Н. (2023) · World Journal of Clinical Oncology · doi:10.5306/wjco.v14.i2.40 · Cited by 79 · see citing works
Guan, Y., Zhang, W., Mao, Y., & Li, S. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02161-1 · Cited by 85 · see citing works
Li, Z., Tang, Y., Xing, W., Dong, W., & Wang, Z. (2017) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2017.12.002 · Cited by 75 · see citing works
MicroRNA-1287-5p promotes ferroptosis of osteosarcoma cells through inhibiting GPX4
Xu, Z., Chen, L., Wang, C., Zhang, L., & Xu, W. (2021) · Free Radical Research · doi:10.1080/10715762.2021.2024816 · Cited by 71 · see citing works
Controlling hypoxia-inducible factor-2α is critical for maintaining bone homeostasis in mice
Lee, S. Y., Park, K. H., Yu, H.-G., Kook, E., Song, W., Lee, G., Koh, J., Shin, H., Choi, J., Huh, Y. H., et al. (2019) · Bone Research · doi:10.1038/s41413-019-0054-y · Cited by 63 · see citing works
Potential anticancer properties and mechanisms of thymoquinone in osteosarcoma and bone metastasis
Homayoonfal, M., Asemi, Z., & Yousefi, B. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00320-0 · Cited by 64 · see citing works
Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma
Wang, C., Jing, J., & Cheng, L. (2018) · Investigational New Drugs · doi:10.1007/s10637-018-0624-7 · Cited by 61 · see citing works
Oncogenic role of SFRP2 in p53-mutant osteosarcoma development via autocrine and paracrine mechanism
Kim, H., Yoo, S., Zhou, R., Xu, A., Bernitz, J. M., Yuan, Y., Gomes, A., Daniel, M. G., Su, J., Demicco, E. G., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814044115 · Cited by 58 · see citing works
Self-citationJerez, S., Araya, H., Hevia, D., Irarrázaval, C. E., Thaler, R., van Wijnen, A. J., & Galindo, M. A. (2019) · Gene · doi:10.1016/j.gene.2019.06.005 · Cited by 58 · see citing works
CircRNA–miRNA networks in regulating bone disease
Huang, W., Wu, Y., Qiao, M., Xie, Z., Cen, X. B., Huang, X., & Zhao, Z. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30625 · Cited by 56 · see citing works
Zhou, R., Xu, A., Gingold, J. A., Strong, L. C., Zhao, R., & Lee, D. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.07.004 · Cited by 52 · see citing works
Self-citationFan, Q., Zuo, J., Tian, H., Huang, C., Nice, E. C., Shi, Z., & Kong, Q. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02372-8 · Cited by 51 · see citing works
FOXP1 drives osteosarcoma development by repressing P21 and RB transcription downstream of P53
Li, H., Han, X., Yang, S., Wang, Y., Dong, Y., & Tang, T. (2021) · Oncogene · doi:10.1038/s41388-021-01742-4 · Cited by 48 · see citing works
Design strategies and evolving role of biomaterial assisted treatment of osteosarcoma
Quadros, M., Momin, M. M., & Verma, G. (2021) · Materials Science and Engineering C · doi:10.1016/j.msec.2021.111875 · Cited by 47 · see citing works
Chen, G., Wang, Q., Yang, Q., Li, Z., Du, Z., Ren, M., Zhao, H., Song, Y., & Zhang, G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202896 · Cited by 45 · see citing works
Hu, Y., Gu, J., Shen, H., Shao, T., Li, S., Wang, W., & Yu, Z. (2019) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23045 · Cited by 44 · see citing works
Xu, S., Gong, Y., Yin, Y., Xing, H., & Zhang, N. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110141 · Cited by 40 · see citing works
MAFG-driven osteosarcoma cell progression is inhibited by a novel miRNA miR-4660
Shan, H., Zhu, L., Yao, C., Zhang, Z.-Q., Liu, Y.-Y., Jiang, Q. L., Zhou, X., Wang, X., & Cao, C. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.03.006 · Cited by 38 · see citing works
Patient-derived induced pluripotent stem cells for models of cancer and cancer stem cell research
Chao, H., & Chern, E. (2018) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.06.013 · Cited by 37 · see citing works
Rodrigues, J., Sarmento, B. F. C. C., & Pereira, C. L. (2022) · In vitro models · doi:10.1007/s44164-022-00008-x · Cited by 39 · see citing works
CDH4 is a novel determinant of osteosarcoma tumorigenesis and metastasis
Tang, Q., Lu, J., Zou, C., Shao, Y. W., Chen, Y., Narala, S., Fang, H., Xu, H., Wang, J., Shen, J., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0231-2 · Cited by 34 · see citing works
Li, C., Zhang, S., Qiu, T., Wang, Y., Ricketts, D., & Qi, C. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1538612 · Cited by 34 · see citing works
RetractedLiu, W., Wang, B., Duan, A., Shen, K., Zhang, Q., Tang, X., Wei, Y., Tang, J. X., & Zhang, S. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02257-4 · Cited by 34 · see citing works
Hereditary retinoblastoma iPSC model reveals aberrant spliceosome function driving bone malignancies
Tu, J., Huo, Z., Yu, Y., Zhu, D., Xu, A., Huang, M.-F., Hu, R., Wang, R., Gingold, J. A., Chen, Y., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2117857119 · Cited by 33 · see citing works
Self-citationLncRNA TUG1 promotes the development of osteosarcoma through RUNX2
Sheng, K., & Li, Y. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7880 · Cited by 32 · see citing works
-, L. S., Ma, D., & Cuili, C. (2020) · Aging · doi:10.18632/aging.103546 · Cited by 32 · see citing works
Identification of Gαi3 as a promising target for osteosarcoma treatment
Bian, Z.-J., Shan, H., Zhu, Y.-R., Shi, C., Chen, M., Huang, Y., Wang, X.-D., Zhou, X., & Cao, C. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.68861 · Cited by 32 · see citing works
Multifunctional nanoparticles for the treatment and diagnosis of osteosarcoma
Yuan, P., Min, Y., & Zhao, Z. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213466 · Cited by 31 · see citing works
ROCK2 promotes osteosarcoma growth and metastasis by modifying PFKFB3 ubiquitination and degradation
Deng, X., Yi, X., Deng, J., Zou, Y., Wang, S., Shan, W., Liu, P., Zhang, Z., Chen, L., & Hao, L. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111689 · Cited by 30 · see citing works
Li, M., Jin, X., Li, H., Wu, G., Wang, S., Yang, C., & Deng, S. (2020) · BMC Cancer · doi:10.1186/s12885-020-6542-z · Cited by 29 · see citing works
LncRNA H19 Suppresses Osteosarcomagenesis by Regulating snoRNAs and DNA Repair Protein Complexes
Xu, A., Huang, M.-F., Zhu, D., Gingold, J. A., Bazer, D. A., Chang, B., Wang, D., Lai, C., Lemischka, I. R., Zhao, R., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.611823 · Cited by 28 · see citing works
Self-citationA Novel Six Metastasis-Related Prognostic Gene Signature for Patients With Osteosarcoma
Zheng, D., Xia, K., Yu, L., Gong, C., Shi, Y., Li, W., Qiu, Y., Yang, J. M., & Guo, W. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.699212 · Cited by 27 · see citing works
B7-H3 in Pediatric Tumors: Far beyond Neuroblastoma
Bottino, C., Vitale, C., Dondero, A., & Castriconi, R. (2023) · Cancers · doi:10.3390/cancers15133279 · Cited by 28 · see citing works
Li, S., Zeng, M., Yang, L., Tan, J., Yang, J., Guan, H., Kuang, M., & Li, J. (2020) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105826 · Cited by 27 · see citing works
Multifunctional 3D-printed bioceramic scaffolds: Recent strategies for osteosarcoma treatment
Liu, X., Liu, Y., Qiang, L., Ya, R., Lin, Y., Li, H., Chen, Q., Gao, S., Yang, X., Zhang, C., et al. (2023) · Journal of Tissue Engineering · doi:10.1177/20417314231170371 · Cited by 28 · see citing works
Self-citationZhu, J., Zhang, Y., Li, Z., Bao, X., Zhou, Y., Ma, B., Xie, Y., Yan, P., Wu, Z., Zhang, Q., et al. (2023) · Materials Horizons · doi:10.1039/d3mh00242j · Cited by 26 · see citing works
Yang, L. G., Jia, J., & Li, S. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.808933 · Cited by 24 · see citing works
The role of m6A methylation in osteosarcoma biological processes and its potential clinical value
Wu, Y., Wang, Z., Shen, J., Yan, W., Xiang, S., Liu, H., & Huang, W. (2022) · Human Genomics · doi:10.1186/s40246-022-00384-1 · Cited by 24 · see citing works
Zeng, J., Peng, Y., Wang, D., Ayesha, K., & Chen, S. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1123065 · Cited by 25 · see citing works
Yang, J., Hu, Y., Wang, L., Sun, X., Yu, L., & Guo, W. (2021) · Bioengineered · doi:10.1080/21655979.2021.2005220 · Cited by 22 · see citing works
Self-citationFu, P., Shi, Y., Chen, G., Fan, Y., Gu, Y., & Gao, Z. (2020) · Technology in Cancer Research & Treatment · doi:10.1177/1533033820947701 · Cited by 22 · see citing works
The potential roles of exosomal noncoding RNAs in osteosarcoma
Li, S., & Wang, X. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30101 · Cited by 22 · see citing works
Modeling cancer progression using human pluripotent stem cell-derived cells and organoids
Zhang, M., Vandana, J. J., Lacko, L. A., & Chen, S. (2020) · Stem Cell Research · doi:10.1016/j.scr.2020.102063 · Cited by 22 · see citing works
Jewell, B. E., Xu, A., Zhu, D., Huang, M.-F., Lu, L., Liu, M., Underwood, E. L., Park, J. H., Fan, H., Gingold, J. A., et al. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009971 · Cited by 19 · see citing works
Self-citationOsteosarcoma Multi-Omics Landscape and Subtypes
Tang, S., Roberts, R. D., Cheng, L., & Li, L. (2023) · Cancers · doi:10.3390/cancers15204970 · Cited by 19 · see citing works
Translational cell biology of highly malignant osteosarcoma
Roessner, A., Lohmann, C. H., & Jechorek, D. (2021) · Pathology International · doi:10.1111/pin.13080 · Cited by 20 · see citing works
Jiang, L., Liao, J., Liu, J., Wei, Q., & Wang, Y. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16725 · Cited by 19 · see citing works
Pin, F., Prideaux, M., Bonewald, L. F., & Bonetto, A. (2021) · Current Osteoporosis Reports · doi:10.1007/s11914-021-00712-9 · Cited by 19 · see citing works
Yao, X., Li, X., Luo, Y., Xu, X., Liu, J., & Bu, J. (2020) · Cancer Management and Research · doi:10.2147/cmar.s251881 · Cited by 17 · see citing works
Zhang, Y., Guo, H., Ma, L., Chen, X., & Chen, G. (2020) · Cancer Management and Research · doi:10.2147/cmar.s269774 · Cited by 15 · see citing works
RetractedLuo, Y., Liu, C., Kirby, J. A., Chu, C., Zang, D., & Chen, J. (2025) · Cancers · doi:10.3390/cancers17132186 · Cited by 15 · see citing works
Zhou, M. D., Wang, A., Yin, B., Wu, D., Han, S., Zhang, W., Liu, J., & Sun, K. (2018) · Oncology Reports · doi:10.3892/or.2018.6822 · Cited by 15 · see citing works
Orai1 Promotes Osteosarcoma Metastasis by Activating the Ras-Rac1-WAVE2 Signaling Pathway
Guo, Y., Zhu, J., Wang, X., Li, R., Jiang, K., Chen, S., Fan, J., Xue, L., & Hao, D. (2019) · Medical Science Monitor · doi:10.12659/msm.919594 · Cited by 15 · see citing works
He, P., Xu, Y., & Wang, Z. (2020) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-020-01865-6 · Cited by 15 · see citing works
Liu, J., Feng, G., Li, Z., Li, R., & Xia, P. (2020) · Cancer Management and Research · doi:10.2147/cmar.s253130 · Cited by 15 · see citing works
RetractedZheng, D., Wei, Z., & Guo, W. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.849789 · Cited by 15 · see citing works
Exosomes in osteosarcoma research and preclinical practice.
Zhang, X., Zhang, R., Su, X., Qi, J., Hu, Y., Shi, J.-T., Zhang, K., Wang, K.-P., & Zhou, H.-Y. (2021) · PubMed Central · Cited by 15 · see citing works
Mishra, A., Kumar, R., Mishra, S. N., Vijayaraghavalu, S., Tiwari, N. K., Shukla, G. C., Gurusamy, N., & Kumar, M. (2023) · Cells · doi:10.3390/cells12081159 · Cited by 14 · see citing works
Yu, D., Xu, X., Li, S., & Zhang, K. (2020) · Aging · doi:10.18632/aging.103043 · Cited by 14 · see citing works
RetractedBa, G., Hua, Z., Xu, N., Zhang, S., Liu, Z., Thiele, C. J., & Li, Z. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1762041 · Cited by 16 · see citing works
Ni, S., Hong, J., Li, W., Ye, M., & Li, J. (2022) · Cancer Medicine · doi:10.1002/cam4.5214 · Cited by 14 · see citing works
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Zhou, R., Xu, A., Tu, J., Liu, M., Gingold, J. A., Zhao, R., & Lee, D. (2018) · Journal of Visualized Experiments · doi:10.3791/57664 · Cited by 16 · see citing works
Self-citationYin, R., Liu, J., Zhao, D., & Wang, F. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s240022 · Cited by 13 · see citing works
RetractedlncRNA HCG11 suppresses human osteosarcoma growth through upregulating p27 Kip1
Gu, J., Dai, B., Shi, X., He, Z., Xu, Y., Meng, X., & Zhu, J. (2021) · Aging · doi:10.18632/aging.203517 · Cited by 13 · see citing works
Generation of human embryonic stem cell line with heterozygous RB1 deletion by CRIPSR/Cas9 nickase
Tu, J., Huo, Z., Liu, M., Wang, D., Xu, A., Zhou, R., Zhu, D., Gingold, J. A., Shen, J., Zhao, R., et al. (2018) · Stem Cell Research · doi:10.1016/j.scr.2018.01.021 · Cited by 13 · see citing works
Self-citationInduced Pluripotent Stem Cells and Induced Pluripotent Cancer Cells in Cancer Disease Modeling
Zhu, D., Kong, C. S. L., Gingold, J. A., Zhao, R., & Lee, D. (2018) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_257 · Cited by 13 · see citing works
Self-citationLiu, L., Pan, J., Wang, H., Ma, Z., Yin, J., Yuan, F., Yuan, Q., Zhou, L., Liu, X., Zhang, Y., et al. (2018) · Bioscience Reports · doi:10.1042/bsr20180372 · Cited by 13 · see citing works
Cancer in a dish: progress using stem cells as a platform for cancer research.
Liu, M., Tu, J., Gingold, J. A., Kong, C. S. L., & Lee, D. (2018) · Europe PMC (PubMed Central) · Cited by 13 · see citing works
Self-citationCircular RNAs in osteosarcoma: An update of recent studies (Review)
Zeng, L., Liu, L., Ni, W.-J., Xie, F., & Leng, X.-M. (2023) · International Journal of Oncology · doi:10.3892/ijo.2023.5571 · Cited by 12 · see citing works
Zhang, B., Du, X., Fan, Y., Qu, G., Pang, L. K., Zhao, R., & Yao, W. (2023) · iScience · doi:10.1016/j.isci.2023.108272 · Cited by 12 · see citing works
Self-citationFrom biology to personalized medicine: Recent knowledge in osteosarcoma
Mohr, A., Costa, M. E. M. D., Fromigué, O., Audinot, B., Balde, T., Droit, R., Abbou, S. D., Khneisser, P., Berlanga, P., Pérez, E., et al. (2024) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2024.104941 · Cited by 13 · see citing works
Li, Z., Jiang, X., Su, Z., Li, J., Kang, P., Li, C., & Cui, Y. (2018) · Pathology - Research and Practice · doi:10.1016/j.prp.2018.07.032 · Cited by 12 · see citing works
He, B., Zhang, W., & He, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.653212 · Cited by 12 · see citing works
Tokumura, K., Fukasawa, K., Ichikawa, J., Sadamori, K., Hiraiwa, M., & Hinoi, E. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07903-7 · Cited by 12 · see citing works
Calycosin induces apoptosis in osteosarcoma cell line via ERβ‑mediated PI3K/Akt signaling pathways
Tian, W., Wang, Z., Yuan, B., & Bao, Y. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11039 · Cited by 11 · see citing works
Xiang, D., Zhang, X., Xue, X., Liang, H., Meng, J., Zhao, S., Yang, J., Zhou, Y., Hu, Y., Xu, L., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120055 · Cited by 10 · see citing works
Computational tools for analyzing single-cell data in pluripotent cell differentiation studies
Ding, J., Alavi, A., Ebrahimkhani, M. R., & Bar‐Joseph, Z. (2021) · Cell Reports Methods · doi:10.1016/j.crmeth.2021.100087 · Cited by 10 · see citing works
Long Non-Coding RNAs as Competitive Endogenous RNAs in Osteosarcoma
Кушлинский, Н. Е., Fridman, M. V., & Александровна, Б. Э. (2020) · Molecular Biology · doi:10.1134/s0026893320050052 · Cited by 10 · see citing works
Cell Differentiation Trajectory-Associated Molecular Classification of Osteosarcoma
Xu, A., Qian, C., Lin, J., Yu, W., Jin, J., Liu, B., & Tao, H. (2021) · Genes · doi:10.3390/genes12111685 · Cited by 10 · see citing works
ZCCHC12 promotes the progression of osteosarcoma via PI3K/AKT pathway
Cui, Y., & Dong, Y.-Y. (2022) · Aging · doi:10.18632/aging.204296 · Cited by 10 · see citing works
Wang, C., Chen, Y., Xiang, H., Wu, X., Tang, Q., Ma, X., & Zhang, L. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.12939 · Cited by 10 · see citing works
Circ_0000885 Enhances Osteosarcoma Progression by Increasing FGFR1 Expression via Sponging MiR-1294
Chen, Y., Zhang, S., Bai, C., Guan, Z., & Chen, W. (2020) · Cancer Management and Research · doi:10.2147/cmar.s244382 · Cited by 9 · see citing works
Jiang, B., Kang, X., Zhao, G., Lu, J., & Wang, Z. (2021) · Computational and Mathematical Methods in Medicine · doi:10.1155/2021/2895893 · Cited by 9 · see citing works
RetractedGuo, Q., Ma, J., & Wu, J. (2021) · Regenerative Therapy · doi:10.1016/j.reth.2021.11.003 · Cited by 9 · see citing works
Wang, L., Song, X., Li-jun, Y., Liu, B., Ma, J., & Yang, W. (2021) · Analytical Cellular Pathology · doi:10.1155/2021/5525711 · Cited by 8 · see citing works
Self-citationRole of ceramides in diabetic foot ulcers (Review)
Wang, Y., Sun, Z., Zang, G., Zhang, L., & Wang, Z. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5229 · Cited by 8 · see citing works
Establishment of a prognostic risk model for osteosarcoma and mechanistic investigation
Jiang, H., Zhao, X., Zang, J., Wang, R., Gao, J., Chen, J., & Yu, T. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1399625 · Cited by 8 · see citing works
Modeling of osteosarcoma with induced pluripotent stem cells
Pang, L. K., Pena, M., Zhao, R., & Lee, D. (2020) · Stem Cell Research · doi:10.1016/j.scr.2020.102006 · Cited by 8 · see citing works
Self-citationING5 is a Potential Target for Osteosarcoma Therapy
Zhang, X., Xu, Z., Xie, H., Sun, Y., Liu, J., & Zhao, Y.-B. (2018) · Technology in Cancer Research & Treatment · doi:10.1177/1533033818762680 · Cited by 8 · see citing works
In Silico Modeling of the Induction of Apoptosis by Cryptotanshinone in Osteosarcoma Cell Lines
Saraf, R., Datta, A. A., Chao Sima, A., Jianping Hua, A., Lopes, R., Bittner, M. L., Miller, T. M., & Wilson-Robles, H. M. (2020) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2020.3037318 · Cited by 8 · see citing works
Yu, Y., Zuo, W., Cai, W., Xu, Y., Liu, W., & Zhao, Z. (2021) · Cancer Management and Research · doi:10.2147/cmar.s284078 · Cited by 7 · see citing works
PTHR1 in osteosarcoma: Specific molecular mechanisms and comprehensive functional perspective
Sun, C., & Li, S. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16420 · Cited by 7 · see citing works
Nanoparticle-driven reactive oxygen species therapy: A new frontier in osteosarcoma treatment
He, L., Habibović, P., & van Rijt, S. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114289 · Cited by 6 · see citing works
Cheng, S., & Wang, W. (2022) · BioMed Research International · doi:10.1155/2022/3261213 · Cited by 6 · see citing works
RetractedcircKMT2D contributes to H2O2‑attenuated osteosarcoma progression via the miR‑210/autophagy pathway
Zhang, J., Chou, X., Zhuang, M., Zhu, C., Hu, Y., Cheng, D., & Liu, Z. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9193 · Cited by 6 · see citing works
- Authors
- Lin, Y.-H., Jewell, B. E., Gingold, J., Lu, L., Zhao, R., Wang, L. L., & Lee, D.-F.
- Affiliations
- The University of Texas Health Science Center at Houston (US)
- The University of Texas MD Anderson Cancer Center (US)
- Cleveland Clinic (US)
- Baylor College of Medicine (US)
- Corresponding author
- Lee, Dung-Fang
- ORCID
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2017-08
- Volume
- 23
- Issue
- 8
- Pages
- 737-755
- ISSN
- 1471-4914 (ISSN-L)
- PMC
- PMC5558609
- OpenAlex
- W2737148036
- Cited by
- 150
- References
- 170
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 9 · 2023: 18 · 2022: 19 · 2021: 34 · 2020: 28 · 2019: 11 · 2018: 16 · 2017: 2
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Trends in Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (AR059063)
- Baylor College of Medicine (BCM) Intellectual and Developmental Disabilities Research Center (IDDRC) (P30HD024064)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Sarcoma Diagnosis and Treatment
- Health Sciences › Medicine › Rheumatology › Bone Tumor Diagnosis and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- osteosarcoma, Li-Fraumeni syndrome, hereditary cancer, induced pluripotent stem cells, iPSC disease models, TP53, in vitro disease model
- MeSH terms
- Animals, Bone Neoplasms, Humans, Models, Biological, Osteosarcoma, Li-Fraumeni Syndrome, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review